Every S-1 that Cycurion, Inc. (CYCU) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A S-1 covers the registration statement a company files to sell shares publicly, so if you follow CYCU and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full CYCU filings page.
Cycurion, Inc. is registering for resale up to 25,888,888 shares of common stock. This includes up to 25,000,000 shares issued or issuable to Yield Point NY LLC under an Equity Purchase Agreement and up to 888,888 shares issuable upon conversion of Series I Convertible Preferred Stock issued in the Secuvant merger.
The Equity Purchase Agreement functions as an equity line, allowing Cycurion to sell shares to Yield Point at 90% of the lowest volume-weighted average price over three trading days, with a maximum commitment of $60 million. Cycurion may receive proceeds from sales to Yield Point, but will not receive proceeds from resales by the selling stockholders.
As of July 2, 2026, Cycurion had 11,472,588 common shares outstanding, while this resale prospectus covers more than twice that amount, highlighting potential dilution and market pressure described in the risk factors, alongside recent acquisitions, debt restructurings and Nasdaq listing risks.
Cycurion, Inc. is registering 7,000,000 shares of common stock for primary issuance under an equity purchase agreement with Yield Point NY LLC and several additional share classes for resale by existing holders. The resale portion covers 119,326 outstanding shares of common stock, 395,866 shares underlying warrants, up to 83,333 shares underlying a pre-funded warrant for Seward & Kissel LLP, and 696,146 shares issuable upon conversion of 3,133 shares of Series G Convertible Preferred Stock. Under the equity purchase agreement, Cycurion may direct Yield Point to buy up to $60 million of stock at 90% of the lowest three-day VWAP, with 25,000,000 authorized shares reserved to support potential draws. The company recently implemented a 1-for-30 reverse stock split effective October 27, 2025, and warns that issuances under the facility could be highly dilutive and pressure its Nasdaq-listed share price.
Cycurion, Inc. has filed a Form S-1 registering a primary offering of up to 7,000,000 shares of common stock that may be issued to Yield Point NY LLC under an Equity Purchase Agreement, an equity line that permits the company to sell shares at 90% of the lowest three‑day VWAP after each put notice, with capacity of up to $60 million in stock sales subject to conditions and future registration. The S-1 also registers secondary resales by selling stockholders of existing common shares, shares underlying public and PIPE warrants, a pre-funded warrant and shares issuable upon conversion of Series G Convertible Preferred Stock, from which the company generally will not receive proceeds other than any cash warrant exercises. The prospectus explains a 1‑for‑30 reverse stock split effective October 27, 2025, outlines Cycurion’s cybersecurity services business and recent Nasdaq notifications confirming compliance with stockholders’ equity and market value listing requirements, and highlights significant risks including dilution, recurring losses, substantial doubt about continued going concern, need for additional funding and potential stock price volatility.